On the other hand, suppressing the IKK–NF-κB pathway in obese and diabetic mice ameliorates diabetes, with a concomitant decrease in gluconeogenic gene expression and gluconegenesis45,53. The gene discussed is NFKB1; the disease is diabetes mellitus.